Walleye Capital LLC Keros Therapeutics, Inc. Transaction History

Walleye Capital LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$41.44 - $59.32 $2.44 Million - $3.49 Million	58,833 Added 668.33%	67,636 $2.89 Million
Q4 2022 Feb 14, 2023	SELL	$39.45 - $51.77 $341,439 - $448,069	-8,655 Reduced 49.58%	8,803 $422,000
Q3 2022 Nov 14, 2022	SELL	$27.8 - $40.12 $629,447 - $908,397	-22,642 Reduced 56.46%	17,458 $657,000
Q2 2022 Aug 08, 2022	BUY	$26.03 - $67.04 $287,735 - $741,060	11,054 Added 38.06%	40,100 $1.11 Million
Q1 2022 May 16, 2022	BUY	$42.12 - $59.36 $1.22 Million - $1.72 Million	29,046 New	29,046 $1.58 Million

157

27.1M

28.7K

1.8K

Ticker KROS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,757,000
Market Cap $1.45B
Description
Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.